Aguilar MG, AlHussen HA, Gandhi PD, Kaur P, Pothacamuri MA, et al. Sepsis-associated acute kidney injury: pathophysiology and treatment modalities. Cureus. 2024;16(12):e75992. https://doi.org/10.7759/cureus.75992.
Article PubMed PubMed Central Google Scholar
Akiyama T, Miyamoto Y, Imai K, Yamashita Y, Nomoto D, Daitoku N, et al. Fibrosis-4 index, a noninvasive fibrosis marker, predicts survival outcomes after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. 2020;27(9):3534–41. https://doi.org/10.1245/s10434-020-08828-5.
Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724–35. https://doi.org/10.1016/S2468-1253(22)00050-4.
Article CAS PubMed PubMed Central Google Scholar
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54. https://doi.org/10.1002/hep.21496.
Article CAS PubMed Google Scholar
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–97. https://doi.org/10.1053/j.gastro.2015.04.043.
Article PubMed PubMed Central Google Scholar
Archer AJ, Belfield KJ, Orr JG, Gordon FH, Abeysekera KW. EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis. Frontline Gastroenterol. 2022;13(5):436–9. https://doi.org/10.1136/flgastro-2021-102064.
Article CAS PubMed PubMed Central Google Scholar
Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56(1):234–40. https://doi.org/10.1016/j.jhep.2011.03.020.
Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61(2):526–36. https://doi.org/10.1002/hep.27431.
Bond MJG, Bolhuis K, Loosveld OJL, de Groot JWB, Droogendijk H, Helgason HH, et al. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group. Lancet Oncol. 2023;24(7):757–71. https://doi.org/10.1016/S1470-2045(23)00219-X.
Article CAS PubMed Google Scholar
Bridgewater JA, Pugh SA, Maishman T, Eminton Z, Mellor J, Whitehead A, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020;21(3):398–411. https://doi.org/10.1016/S1470-2045(19)30798-3.
Article CAS PubMed PubMed Central Google Scholar
Charalambides M, Mavrou A, Jennings T, Powar MP, Wheeler J, Davies RJ, et al. A systematic review of the literature assessing operative blood loss and postoperative outcomes after colorectal surgery. Int J Colorectal Dis. 2022;37(1):47–69. https://doi.org/10.1007/s00384-021-04015-4.
Cheng YX, Tao W, Zhang H, Peng D, Wei ZQ. Does liver cirrhosis affect the surgical outcome of primary colorectal cancer surgery? A meta-analysis. World J Surg Oncol. 2021;19(1):167. https://doi.org/10.1186/s12957-021-02267-6.
Article PubMed PubMed Central Google Scholar
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.
Das DS, Anupam A, Saharia GK. Association between liver fibrosis scores and short-term clinical outcomes in hospitalized chronic kidney disease patients: a prospective observational study. Front Med. 2024;11:1387472. https://doi.org/10.3389/fmed.2024.1387472.
Dorcaratto D, Mazzinari G, Fernandez M, Munoz E, Garces-Albir M, Ortega J, Sabater L. Impact of postoperative complications on survival and recurrence after resection of colorectal liver metastases: Systematic review and meta-analysis. Ann Surg. 2019;270(6):1018–27. https://doi.org/10.1097/SLA.0000000000003254.
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005. https://doi.org/10.1016/j.jhep.2004.11.015.
Egeland C, Rostved AA, Schultz NA, Pommergaard HC, Daugaard TR, Thofner LB, et al. Morbidity and mortality after liver surgery for colorectal liver metastases: a cohort study in a high-volume fast-track programme. BMC Surg. 2021;21(1):312. https://doi.org/10.1186/s12893-021-01301-4.
Article PubMed PubMed Central Google Scholar
Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2010;51(2):585–94. https://doi.org/10.1002/hep.23315.
Article PubMed PubMed Central Google Scholar
Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999;29(6):1617–23. https://doi.org/10.1002/hep.510290639.
Article CAS PubMed Google Scholar
Ghiasloo M, Pavlenko D, Verhaeghe M, Van Langenhove Z, Uyttebroek O, Berardi G, et al. Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: a systematic review and network meta-analysis. Eur J Surg Oncol. 2020;46(7):1203–13. https://doi.org/10.1016/j.ejso.2020.02.040.
Giakoustidis A, Papakonstantinou M, Chatzikomnitsa P, Gkaitatzi AD, Bangeas P, Loufopoulos PD, et al. The effects of sarcopenia on overall survival and postoperative complications of patients undergoing hepatic resection for primary or metastatic liver cancer: A systematic review and meta-analysis. J Clin Med. 2024. https://doi.org/10.3390/jcm13133869.
Article PubMed PubMed Central Google Scholar
Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology. 2018;155(2):391–410. https://doi.org/10.1053/j.gastro.2018.05.012.
Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–76. https://doi.org/10.1016/S0140-6736(21)01374-X.
Hu X, Marietta A, Dai WX, Li YQ, Ma XJ, Zhang L, et al. Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores. Clin Transl Med. 2020;9(1):13. https://doi.org/10.1186/s40169-020-0264-3.
Article PubMed PubMed Central Google Scholar
Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 2021;75(6):1476–84. https://doi.org/10.1016/j.jhep.2021.08.012.
Kamath PS, Kim WR, Advanced Liver Disease Study G. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–805. https://doi.org/10.1002/hep.21563.
Keck J, Gaedcke J, Ghadimi M, Lorf T. Surgical therapy in patients with colorectal liver metastases. Digestion. 2022;103(4):245–52. https://doi.org/10.1159/000524022.
Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. https://doi.org/10.1038/s41572-021-00284-z.
Kondo T, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kitagawa Y. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer. Br J Cancer. 2016;115(1):34–9.
Comments (0)